A Phase Ⅲ Clinical Study of SNA02-48 Injection
Clinical trial NCT07633119 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07633119
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-28
- Primary completion
- 2027-03-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.